The table below shows Zymeworks Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$33.01M
-$110.06M
-$118.32M
$144.11M
-$192.45M
-$151.40M
Capital expenditure
$1.52M
$1.99M
$2.47M
$8.15M
$12.40M
$4.31M
Investing cash flow
$26.66M
$38.76M
-$207.25M
-$53.85M
$144.60M
-$43.44M
Dividends paid
-
-
-
-
-
ZYME operating cash flow (10-K history)
Zymeworks Inc. reported operating cash flow of -$33.01M for fiscal year 2025. That is up 70.0% from -$110.06M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from -$151.40M (FY 2020) to -$33.01M. Figures come from the company's audited annual reports as filed with the SEC.
